4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-19-009061
Options or other derivatives
- President and CEO acquired 327,831 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Watts Ryan J. President and CEO | 2019-02-08 | Grant or award · Restricted Stock Units | +11,031 | 11,031 | D | ||
| Watts Ryan J. President and CEO | 2019-02-08 | Grant or award · Restricted Stock Units | +35,200 | 35,200 | D | ||
| Watts Ryan J. President and CEO | 2019-02-08 | Grant or award · Stock Option (right to buy) | +281,600 | 281,600 | D | ||
Loading xslF345X03/doc4.xml…